Knowledge, Attitude and Practice about Glucagon-like Peptide-1 Receptor Agonist Among the Physicians of Prince Mohammed bin Abdulaziz Hospital & Primary Health Care, National Guard, Saudi Arabia
Glucagon-like peptide-1 receptor agonist (GLP-1RA) is a newly approved medication in the management of Diabetes Mellitus. GLP-1RA has potential adverse effects and risks such as gastrointestinal symptoms, pancreatitis, and thyroid cell neoplasia, respectively. A cross-sectional study, through a...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Krupanidhi College of Pharmacy
2025-03-01
|
| Series: | Journal of Pharmaceutical Research |
| Online Access: | https://jopcr.com/articles/knowledge-attitude-and-practice-about-glucagon-like-peptide-1-receptor-agonist-among-the-physicians-of-prince-mohammed-bin-abdulaziz-hospital-primary-health-care-national-guard-saudi-arabia |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Glucagon-like peptide-1 receptor agonist (GLP-1RA) is a newly approved medication in the management of Diabetes Mellitus. GLP-1RA has potential adverse effects and risks such as gastrointestinal symptoms, pancreatitis, and thyroid cell neoplasia, respectively. A cross-sectional study, through a validated questionnaire with fixed answers, was utilized to assess the physician’s response regarding GLP-1RA. Participants were Saudi females, younger than 35 years. Physicians with variable educational degrees were included. In regard to prescription authority, it was limited to only around 25.5% of the treating physicians. Knowledge items were scored correctly by 77.2% of participants. And around half of the group 51.6% showed a positive attitude toward GLP-1RA, reflected as strongly agree and agree in the questionnaire. And only 55.2% of participants showed good practice in terms of utilization of GLP-1RA. These findings suggest that continuous professional development and well-organized training programs are crucial to bridge knowledge gaps and refine practice patterns.
Keywords: Knowledge, Attitude, Practice, Glucagon-like peptide-1 receptor agonist, Physicians |
|---|---|
| ISSN: | 0973-7200 2454-8405 |